[1] SIEGEL R L, MILLER K D, JEMAL A.Cancer statistics, 2016[J]. CA Cancer J Clin, 2016, 66(1): 7-30.
[2] COOPERBERG M R, BROERING J M, KANTOFF P W, et al.Contemporary trends in low risk prostate cancer: risk assessment and treatment[J]. Urol, 2007, 178(3Pt2): S14-19.
[3] 韩苏军,张思维,陈万青,等.中国前列腺癌发病现状和流行趋势分析[J].临床病理学杂志,2013,18(4):330-334.
[4] DANNEMAN D, DREVIN L, ROBINSON D, et al.Gleason inflation 1998-2011:a registry study of 97, 168 men[J]. BJU Int, 2015, 115(2): 248-255.
[5] CORCORAN N M, CASEY R G, HONG M K, et al.The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume[J]. BJU Int,2012,110(1): 36-42.
[6] DINH K T, MAHAL B A, ZIEHR D R, et al.Incidence and Predictors of Upgrading and Up Staging among 10000 Contemporary Patients with Low Risk Prostate Cancer[J]. Urol, 2015, 194(2): 343-349.
[7] JALLOH M, MYERS F, COWAN J E, et al.Racial variation in prostate cancer upgrading and upstaging among men with low-risk clinical characteristics[J]. Eur Urol, 2015, 67(3): 451-457.
[8] REIS L O, SANCHES B C, DE MENDONCA G B, et al. Gleason underestimation is predicted by prostate biopsy core length[J]. World J Urol, 2015, 33(6): 821-826.
[9] SEISEN T, ROUDOT-THORAVAL F, BOSSET P O, et al.Predicting the risk of harboring high-grade disease for patients diagnosed with prostate cancer scored as Gleason≤6 on biopsy cores[J]. World J Urol, 2015, 33(6): 787-792.
[10] LEE F, GOTTSCH H, ELLIS W J, et al.Differences in Upgrading of Prostate Cancer in Prostatectomies between Community and Academic Practices[J]. Adv Urol, 2013, 2013: 471234.
[11] GERSHMAN B, DAHL D M, OLUMI A F, et al.Smaller prostate gland size and older age predict Gleason score upgrading[J]. Urol Oncol, 2013, 31(7): 1033-1037.
[12] KIM K H, LIM S K, SHIN T Y, et al.Upgrading of Gleason score and prostate volume:a clinicopathological analysis[J]. BJU Int, 2013, 111(8): 1310-1316.
[13] TRUONG M, SLEZAK J A, LIN C P, et al.Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancer[J]. Cancer, 2013, 119(22): 3992-4002.
[14] SFOUNGARISTOS S, PERIMENIS P.Clinical and pathological variables that predict changes in tumour grade after radical prostatectomy in patients with prostate cancer[J]. Can Urol Assoc J, 2013, 7(1-2): E93-97.
[15] SFOUNGARISTOS S, KATAFIGIOTIS I, PERIMENIS P.The role of PSA density to predict a pathological tumour upgrade between needle biopsy and radical prostatectomy for low risk clinical prostate cancer in the modified Gleason system era[J]. Can Urol Assoc J, 2013, 7(11-12): E722-727.
[16] CHAMIE K, SONN G A, FINLEY D S, et al.The role of magnetic resonance imaging in delineating clinically significant prostate cancer[J]. Urology, 2014, 83(2): 369-375.
[17] ABD-ALAZEEZ M, AHMED H U, ARYA M, et al.Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultra sound biopsy results at more definitive histology[J]. Urol Oncol, 2014, 32(6): 741-747.
[18] PARK B H, JEON H G, CHOO S H, et al.Role of multiparametric 3.0-Tesla magnetic resonance imaging in patients with prostate cancer eligible for active surveillance[J]. BJU Int, 2014, 113(6): 864-870.
[19] MEARINI L, NUNZI E, FERRI C, et al.Use of the prostate health index for the detection of aggressive prostate cancer at radical prostatectomy[J]. Urol Int, 2015, 95(4): 390-399.
[20] GONDO T, POON B Y, MATSUMOTO K, et al.Clinical role of pathological downgrading after radical prostatectomy in patients with biopsy confirmed Gleason score 3+4 prostate cancer[J]. BJU Int, 2015, 115(1): 81-86.
[21] REIS L O, ZANI E L, FREITAS L L, at al. Higher prostate weight is inversely associated with Gleason score upgrading in radical prostatectomy specimens[J]. Adv Urol, 2013, 2013: 710421.
[22] EPSTEIN J I, FENG Z, TROCK B J, et al.Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades[J]. Eur Urol, 2012, 61(5): 1019-1024.
[23] EPSTEIN J I, EGEVAD L, AMIN M B, et al.The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System[J]. Am J Surg Pathol, 2016, 40(2): 244-252. |
